{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"samd9-related-spectrum-and-myeloid-neoplasm-risk","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"A susceptibility or predisposition to MIRAGE syndrome and monosomy 7 myelodysplasia and leukemia syndrome 2, in which the cause of the disease is a mutation in the SAMD9 gene.","mondoId":"MONDO:0100628","node":{"canonicalSlug":"samd9-related-spectrum-and-myeloid-neoplasm-risk","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"SAMD9-related spectrum and myeloid neoplasm risk","paragraphs":["A susceptibility or predisposition to MIRAGE syndrome and monosomy 7 myelodysplasia and leukemia syndrome 2, in which the cause of the disease is a mutation in the SAMD9 gene."],"scope":"exact","source":"MONDO","upstream":"https://clinicalgenome.org/affiliation/40157/, https://orcid.org/0009-0004-3069-7846, MONDO:patterns/susceptibility_by_gene","url":"https://monarchinitiative.org/MONDO:0100628"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"hereditary neoplastic syndrome","mondoId":"MONDO:0015356","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/28005"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100628\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>https://clinicalgenome.org/affiliation/40157/, https://orcid.org/0009-0004-3069-7846, MONDO:patterns/susceptibility_by_gene</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A susceptibility or predisposition to MIRAGE syndrome and monosomy 7 myelodysplasia and leukemia syndrome 2, in which the cause of the disease is a mutation in the SAMD9 gene.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100628\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"samd9-related-spectrum-and-myeloid-neoplasm-risk","sourceDocuments":[{"name":"MONDO: SAMD9-related spectrum and myeloid neoplasm risk","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100628"}],"sourceNote":"","synonyms":["MIRAGE syndrome susceptibility, SAMD9 form","SAMD9-related spectrum and myeloid neoplasm risk"],"takeawayHtml":"","title":"SAMD9-related spectrum and myeloid neoplasm risk"},"schemaVersion":1}
